Loading clinical trials...

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease | Clinical Trials | Clareo Health

COMPLETED

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

A Cross-Sectional Non-Interventional Study to Assess Walking Performance, Quality of Life, Vascular Function, and Lower Limb Arterial Calcification in Subjects With Peripheral Artery Disease and ESKD Receiving Hemodialysis

NCT04487301•Sanifit Therapeutics S. A.

View on ClinicalTrials.gov

Summary

A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.

Eligibility

Age

45 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•≥55 years of age or ≥45 years of age with diabetes
•Receiving maintenance HD in a clinical setting for at least 2 weeks prior to screening
•Resting ABI \<0.90 in either leg OR Resting TBI \<0.70 in either leg
•Symptomatic as characterized by a limitation in exercise performance

Exclusion Criteria

•Above-ankle amputation
•Chronic limb-threatening ischemia (Rutherford 4-6)
•Non-ambulatory status
•A condition other than PAD that limits ability to walk
•Open or endovascular revascularization within 3 months prior to baseline.
•Illnesses, conditions, or planned surgeries within the study period that will interfere with the interpretation of the study results

Locations (7)

Valley Renal Medical Group

Northridge, California, United States

Horizon Medical Research

Coral Gables, Florida, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Boston Medical Center

Boston, Massachusetts, United States

St Louis Kidney Care

St Louis, Missouri, United States

Mountain Kidney & Hypertension Associates

Asheville, North Carolina, United States

Houston Medical Research

Houston, Texas, United States

Key Dates

Start Date

November 16, 2020

Primary Completion Date

June 12, 2021

Completion Date

June 12, 2021

Last Updated

October 14, 2021

Enrollment

ACTUAL participants

Conditions

Peripheral Artery DiseaseEnd Stage Renal Disease on Dialysis

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

NCT07283289

Peripheral Artery Disease

View study

RECRUITINGEARLY_PHASE1

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

NCT06212271

Peripheral Artery Disease

View study

RECRUITING

Vascular Lab Resource (VLR) Biorepository

NCT05628948

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

Inclusion Criteria

Exclusion Criteria

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

Vascular Lab Resource (VLR) Biorepository

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

The COCOA-PAD II Trial

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease